ICD-10-CM Billable Code

H51.23

Internuclear ophthalmoplegia, bilateral

Clinical Classification Guidelines

Medical Intelligence & Overview

Bilateral internuclear ophthalmoplegia (INO) is a neurological condition that impacts eye movement. It affects the coordination between the eyes, resulting in difficulty in moving both eyes together. This condition is associated with damage to specific nerve pathways in the brainstem, which are responsible for horizontal eye movements. People with bilateral INO may experience double vision and trouble focusing, which can interfere with daily activities and quality of life.

Causes & Symptoms

Clinical Causes: Multiple sclerosis, especially in younger adults Brainstem strokes or vascular accidents affecting the medial longitudinal fasciculus Brain tumors or lesions that impact the brainstem Traumatic brain injuries leading to damage in the brainstem area Infections or inflammatory conditions affecting the nervous system

Key Symptoms: Double vision (diplopia), especially when looking side to side Difficulty coordinating eye movements Inability to move both eyes equally in lateral gaze Nystagmus, which involves involuntary eye movements, in one or both eyes Possible dizziness or imbalance due to impaired eye coordination In some cases, eyelid drooping or weakness

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a thorough eye examination and neurological assessment. An eye doctor or neurologist will evaluate eye movements, check for nystagmus, and perform specific tests to observe how both eyes move together. Brain imaging techniques like MRI or CT scans are often used to identify underlying causes such as lesions or strokes affecting the brainstem. Additional tests may include visual field assessments and blood work to help pinpoint the top cause.

Treatment Protocols: While there is no cure for bilateral internuclear ophthalmoplegia itself, treatment focuses on managing symptoms and addressing the underlying cause. Interventions may include: - Disease-specific therapies, such as immunomodulatory treatments for multiple sclerosis - Visual aids or prisms to help reduce double vision - Physical therapy to improve coordination and balance - Close monitoring by healthcare providers to prevent or manage complications related to the primary cause In some cases, neurological recovery may occur over time, especially if the underlying condition is effectively treated.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H51.23 a billable ICD-10 code?
Yes, H51.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H51.23?
Clinical documentation must specify the nature of Internuclear ophthalmoplegia, bilateral and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

internuclear bilateral